Boston Scientific
- Mapping and Ablation
- Venous Therapies
- Cardiac Rhythm Management
- Structural Heart
- Interventional Oncology
- Drug-Eluting Technologies
- Coronary
Playback speed
10 seconds
Reducing Repeat Procedures and Treating Complex Lesions: A Review of New Drug-Eluting Technology for the SFA
0 views
December 11, 2020
Dr. Michael Jaff, Dr. Robert Lookstein, and Dr. Ravish Sachar discuss the use of Eluvia ...
read more ↘ DES and Ranger DCB for the treatment of superficial femoral artery disease. Hear about recent clinical data and the importance of durability in the time of COVID-19.
↖ read less
read more ↘ DES and Ranger DCB for the treatment of superficial femoral artery disease. Hear about recent clinical data and the importance of durability in the time of COVID-19.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Drug-Eluting Technologies